Barbara Jereczek-Fossa, President of ESTRO and Radiation Oncologist at the European Institute of Oncology and University of Milan, shared on LinkedIn:
“Huge thanks to our wonderful Polish colleagues Prof. Jacek Fijuth and Łukasz Kuncman for their warmth, friendship and inspiring energy at PTRO!
Excited about the new joint European Society for Radiotherapy and Oncology (ESTRO) – Polish Society of Radiotherapy and Oncology (PTRO) membership!”
Main topics discussed at ‘4R – Radiation Therapists Discuss Radiotherapy and Radiobiology with Their Peers’ conference
Advances in lung cancer radiotherapy: Discussions addressed treatment selection for unresectable and potentially resectable non-small-cell lung cancer,
- chemoradiotherapy sequencing
- consolidation durvalumab
- integration of radiotherapy with immunotherapy in small-cell lung cancer.
Personalized radiotherapy for breast and prostate cancer: Sessions examined indications for
- postmastectomy irradiation
- radiotherapy de-escalation
- lymph-node irradiation
- androgen deprivation therapy
- treatment optimization based on patients’ clinical characteristics.
Innovative radiation techniques and organ preservation: Experts discussed
- stereotactic body radiotherapy (SBRT)
- brachytherapy
- reirradiation
- hypofractionated treatment approaches,
including their safety, efficacy, and potential to preserve organs in bladder, rectal, and cervical cancers.
Integrating radiotherapy with systemic treatment: The program explored
- combining radiation with immunotherapy and systemic therapies
- emerging treatment strategies for brain and head-and-neck tumors
- evidence-based approaches to improving survival while reducing treatment-related morbidity
You may also be interested in:
Barbara Jereczek-Fossa: All Roads Lead to Milan, 30 Days Left to Make Your Research Part of ESTRO 2027
